269 related articles for article (PubMed ID: 18438409)
1. Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation.
Wilker PR; Kohyama M; Sandau MM; Albring JC; Nakagawa O; Schwarz JJ; Murphy KM
Nat Immunol; 2008 Jun; 9(6):603-12. PubMed ID: 18438409
[TBL] [Abstract][Full Text] [Related]
2. Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cells.
Andrews SF; Dai X; Ryu BY; Gulick T; Ramachandran B; Rawlings DJ
Eur J Immunol; 2012 May; 42(5):1327-36. PubMed ID: 22311635
[TBL] [Abstract][Full Text] [Related]
3. A p38 MAPK-MEF2C pathway regulates B-cell proliferation.
Khiem D; Cyster JG; Schwarz JJ; Black BL
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17067-72. PubMed ID: 18955699
[TBL] [Abstract][Full Text] [Related]
4. The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes.
Tan JE; Wong SC; Gan SK; Xu S; Lam KP
J Biol Chem; 2001 Jun; 276(23):20055-63. PubMed ID: 11274146
[TBL] [Abstract][Full Text] [Related]
5. B Cell Development sans B Cell Receptor Responsiveness Due to Unfolded Protein Response-Triggered Mef2c Protein Degradation.
Chen YT; Su YC; Kung JT
J Immunol; 2018 Nov; 201(10):2885-2898. PubMed ID: 30305329
[TBL] [Abstract][Full Text] [Related]
6. Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis.
Gekas C; Rhodes KE; Gereige LM; Helgadottir H; Ferrari R; Kurdistani SK; Montecino-Rodriguez E; Bassel-Duby R; Olson E; Krivtsov AV; Armstrong S; Orkin SH; Pellegrini M; Mikkola HK
Blood; 2009 Apr; 113(15):3461-71. PubMed ID: 19211936
[TBL] [Abstract][Full Text] [Related]
7. Myocyte enhancer factor-related B-MEF2 is developmentally expressed in B cells and regulates the immunoglobulin J chain promoter.
Rao S; Karray S; Gackstetter ER; Koshland ME
J Biol Chem; 1998 Oct; 273(40):26123-9. PubMed ID: 9748293
[TBL] [Abstract][Full Text] [Related]
8. Calreticulin signals upstream of calcineurin and MEF2C in a critical Ca(2+)-dependent signaling cascade.
Lynch J; Guo L; Gelebart P; Chilibeck K; Xu J; Molkentin JD; Agellon LB; Michalak M
J Cell Biol; 2005 Jul; 170(1):37-47. PubMed ID: 15998798
[TBL] [Abstract][Full Text] [Related]
9. Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes.
Swanson BJ; Jäck HM; Lyons GE
Mol Immunol; 1998 Jun; 35(8):445-58. PubMed ID: 9798649
[TBL] [Abstract][Full Text] [Related]
10. NFATc1 affects mouse splenic B cell function by controlling the calcineurin--NFAT signaling network.
Bhattacharyya S; Deb J; Patra AK; Thuy Pham DA; Chen W; Vaeth M; Berberich-Siebelt F; Klein-Hessling S; Lamperti ED; Reifenberg K; Jellusova J; Schweizer A; Nitschke L; Leich E; Rosenwald A; Brunner C; Engelmann S; Bommhardt U; Avots A; Müller MR; Kondo E; Serfling E
J Exp Med; 2011 Apr; 208(4):823-39. PubMed ID: 21464221
[TBL] [Abstract][Full Text] [Related]
11. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice.
Xu J; Gong NL; Bodi I; Aronow BJ; Backx PH; Molkentin JD
J Biol Chem; 2006 Apr; 281(14):9152-62. PubMed ID: 16469744
[TBL] [Abstract][Full Text] [Related]
12. MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines.
Nagel S; Meyer C; Quentmeier H; Kaufmann M; Drexler HG; MacLeod RA
Leukemia; 2008 Mar; 22(3):600-7. PubMed ID: 18079734
[TBL] [Abstract][Full Text] [Related]
13. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
Glassford J; Soeiro I; Skarell SM; Banerji L; Holman M; Klaus GG; Kadowaki T; Koyasu S; Lam EW
Oncogene; 2003 Apr; 22(15):2248-59. PubMed ID: 12700661
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells.
Maiti D; Xu Z; Duh EJ
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3640-8. PubMed ID: 18450586
[TBL] [Abstract][Full Text] [Related]
15. Myocyte enhancer factor 2 mediates calcium-dependent transcription of the interleukin-2 gene in T lymphocytes: a calcium signaling module that is distinct from but collaborates with the nuclear factor of activated T cells (NFAT).
Pan F; Ye Z; Cheng L; Liu JO
J Biol Chem; 2004 Apr; 279(15):14477-80. PubMed ID: 14722108
[TBL] [Abstract][Full Text] [Related]
16. The MADS transcription factor Mef2c is a pivotal modulator of myeloid cell fate.
Schüler A; Schwieger M; Engelmann A; Weber K; Horn S; Müller U; Arnold MA; Olson EN; Stocking C
Blood; 2008 May; 111(9):4532-41. PubMed ID: 18326819
[TBL] [Abstract][Full Text] [Related]
17. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
18. Protein phosphatase subunit G5PR is needed for inhibition of B cell receptor-induced apoptosis.
Xing Y; Igarashi H; Wang X; Sakaguchi N
J Exp Med; 2005 Sep; 202(5):707-19. PubMed ID: 16129705
[TBL] [Abstract][Full Text] [Related]
19. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
[TBL] [Abstract][Full Text] [Related]
20. mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo.
Dodou E; Xu SM; Black BL
Mech Dev; 2003 Sep; 120(9):1021-32. PubMed ID: 14550531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
